Humana (United States)

本机构学者在这里署名、按本站篇数

合作机构同一篇文章里的其他机构

1. Harvard University美国8
2. Carelon Research (United States)美国6
3. United States Food and Drug Administration美国5
4. Pfizer (United States)美国4
5. Aetna (United States)美国3
6. University of Massachusetts Chan Medical School美国3
7. University of Pennsylvania美国3
8. Astellas Pharma (Netherlands)荷兰2

按月发文

逐年被引

最新文献

1. 1
   Lessons learned from a multi‐data source research collaboration: The mirabegron post‐authorization safety study programPharmacoepidemiology and Drug Safety20240
2. 2
   SARS-CoV-2 incidence monitoring and statistical estimation of the basic and time-varying reproduction number at the early onset of the pandemic in 45 sub-Saharan African countriesBMC Public Health20245
3. 3
   Effect of interventions for non-emergent medical transportation: a systematic review and meta-analysisBMC Public Health202270
4. 4
   Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort StudyDrug Safety202125
5. 5
   Validation of an electronic algorithm for Hodgkin and non‐Hodgkin lymphoma in ICD‐10‐CMPharmacoepidemiology and Drug Safety202110
6. 6
   Validity of ICD‐10‐CM diagnoses to identify hospitalizations for serious infections among patients treated with biologic therapiesPharmacoepidemiology and Drug Safety202129
7. 7
   Identifying prescribing cascades in Alzheimer's disease and related dementias: The calcium channel blocker‐diuretic prescribing cascadePharmacoepidemiology and Drug Safety202125
8. 8
   Diagnostic Algorithms for Cardiovascular Death in Administrative Claims Databases: A Systematic ReviewDrug Safety201818
9. 9
   Do FDA label changes work? Assessment of the 2010 class label change for proton pump inhibitors using the Sentinel System's analytic toolsPharmacoepidemiology and Drug Safety201817
10. 10
    Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel SystemPharmacoepidemiology and Drug Safety201823

高被引文献

1. 1
   Effect of interventions for non-emergent medical transportation: a systematic review and meta-analysisBMC Public Health202270
2. 2
   A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety SurveillanceDrug Safety201560
3. 3
   Prospective influenza vaccine safety surveillance using fresh data in the Sentinel SystemPharmacoepidemiology and Drug Safety201530
4. 4
   Validity of ICD‐10‐CM diagnoses to identify hospitalizations for serious infections among patients treated with biologic therapiesPharmacoepidemiology and Drug Safety202129
5. 5
   Identifying prescribing cascades in Alzheimer's disease and related dementias: The calcium channel blocker‐diuretic prescribing cascadePharmacoepidemiology and Drug Safety202125
6. 6
   Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort StudyDrug Safety202125
7. 7
   Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel SystemPharmacoepidemiology and Drug Safety201823
8. 8
   Diagnostic Algorithms for Cardiovascular Death in Administrative Claims Databases: A Systematic ReviewDrug Safety201818
9. 9
   Do FDA label changes work? Assessment of the 2010 class label change for proton pump inhibitors using the Sentinel System's analytic toolsPharmacoepidemiology and Drug Safety201817
10. 10
    Methods for using clinical laboratory test results as baseline confounders in multi‐site observational database studies when missing data are expectedPharmacoepidemiology and Drug Safety201614

主要发表期刊